SCIENCE CHINA Life Sciences, Volume 60 , Issue 3 : 326-328(2017) https://doi.org/10.1007/s11427-016-0373-3

Will cancer cells be defeated by sodium bicarbonate?

More info
  • ReceivedNov 30, 2016
  • AcceptedDec 6, 2016
  • PublishedJan 4, 2017


There is no abstract available for this article.

Funded by

Breast Cancer Research Foundation and the National Institutes of Health to M.I.G.(R01CA089481,R01CA149425)

DOD IDEA grant to S.S.(W81XWH-15-1-0362)


This work was supported by the Breast Cancer Research Foundation and the National Institutes of Health to Mark I. Greene (R01CA089481, R01CA149425), and the Department of Defense Lung Cancer Research Program Idea Development Award grant to Sunil Singhal (W81XWH-15-1-0362). Mr. Cameron Jeffers kindly read the manuscript and provided discussions and suggestions.

Interest statement

The author(s) declare that they have no conflict of interest.


[1] Band, P.R., Maroun, J., Pritchard, K., Stewart, D., Coppin, C.M., Wilson, K., and Eisenhauer, E.A. (1986). Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study. Cancer Treat Rep 70, 1305–1310. Google Scholar

[2] Chao M., Wu H., Jin K., Li B., Wu J., Zhang G., Yang G., Hu X.. A nonrandomized cohort and a randomized study of local control of large hepatocarcinoma by targeting intratumoral lactic acidosis. eLife, 2016, 5: e15691 CrossRef PubMed Google Scholar

[3] DeAngelo A.B., Daniel F.B., Stober J.A., Olson G.R.. The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse. Fundam Appl Toxicol, 1991, 16: 337-347 CrossRef Google Scholar

[4] Dorff T.B., Groshen S., Garcia A., Shah M., Tsao-Wei D., Pham H., Cheng C.W., Brandhorst S., Cohen P., Wei M., Longo V., Quinn D.I.. Safety and feasibility of fasting in combination with platinum-based chemotherapy. BMC Cancer, 2016, 16: 360 CrossRef PubMed Google Scholar

[5] Ganapathy-Kanniappan S., Geschwind J.F.H.. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer, 2013, 12: 152 CrossRef PubMed Google Scholar

[6] He Q., Lu W.S., Liu Y., Guan Y.S., Kuang A.R.. 131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma. World J Gastroenterol, 2013, 19: 9104-9110 CrossRef PubMed Google Scholar

[7] Marchiq I., Pouysségur J.. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H+ symporters. J Mol Med, 2016, 94: 155-171 CrossRef PubMed Google Scholar

[8] Qorraj M., Bruns H., Böttcher M., Weigand L., Saul D., Mackensen A., Jitschin R., Mougiakakos D.. The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia. Leukemia, 2016, : in press doi: 10.1038/leu.2016.214 CrossRef PubMed Google Scholar

[9] Schwartz K., Chang H.T., Nikolai M., Pernicone J., Rhee S., Olson K., Kurniali P.C., Hord N.G., Noel M.. Treatment of glioma patients with ketogenic diets: report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature. Cancer Metab, 2015, 3: 3 CrossRef PubMed Google Scholar

[10] Wu H., Ding Z., Hu D., Sun F., Dai C., Xie J., Hu X.. Central role of lactic acidosis in cancer cell resistance to glucose deprivation-induced cell death. J Pathol, 2012, 227: 189-199 CrossRef PubMed Google Scholar

  • Figure 1

    (Color online) Glycolysis in cancer cells. Cancer cells are dependent on glycolysis for energy and produce lactate and protons (H+) as metabolites, which are pumped out of cells and create an acidic immune-suppressive tumor microenvironment. By neutralizing H+, the sodium bicarbonate in the TILA-TACE procedure was shown to improve the clinical outcomes of TACE.


Contact and support